| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.04 |